SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-07-003574
Filing Date
2007-04-16
Accepted
2007-04-16 08:30:16
Documents
2
Period of Report
2007-04-16
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AVANT IMMUNOTHERAPEUTICS, INC. 8-K a5377117.txt 8-K 5254
2 EXHIBIT 99.1 a5377117-ex991.txt EX-99.1 7103
  Complete submission text file 0001157523-07-003574.txt   13976
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 07767200
SIC: 2835 In Vitro & In Vivo Diagnostic Substances